You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Sale Disclosure
Schoenberg Mark · SEC Form 4 · Filed Aug 24, 2026
Sale
Calculated transaction value
$2.85M
Schoenberg Mark Chief Medical Officer
URGN
UroGen Pharma Ltd
URGN
Transaction date
Aug 20, 2026
Public filing date
Aug 24, 2026
Filing lag
Filed 4 days later
URGN daily price context
Close on/before transaction
$46.8
Aug 20, 2026
First close after public filing
$46.36
Aug 25, 2026
30-day return after filing
-10.2%
Through Sep 23, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- ordinary shares
- Quantity / price
- 60,677 shares @ $47.05
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001437749-26-028840
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$2.85M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN Current | Sale | Aug 20, 2026 | $2.85M |